Guardant Health, Inc. (GH): Operating Cash Flow
-$184.76M
Year ended 2025-12-31
-$185.19M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$184.76M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$239.86M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$324.98M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$309.46M | n/m | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | -$209.02M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | -$103.93M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$47.13M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$72.19M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$72.23M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$36.71M | n/a | 2019-03-19, From 2016-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | -$184.76M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $83.16M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $136.31M | +81.5% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $298.82M | +28.2% |
| Natera, Inc. (NTRA) | 2025-12-31 | $215.30M | +58.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $42.03M | +10.5% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $113.50M | -56.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $64.35M | -0.8% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$101.64M | n/m |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗